ACRS
Price
$1.56
Change
-$0.07 (-4.29%)
Updated
Jun 26 closing price
Capitalization
168.92M
40 days until earnings call
ANIK
Price
$10.84
Change
-$0.39 (-3.47%)
Updated
Jun 26, 04:59 PM (EDT)
Capitalization
381.94M
35 days until earnings call
Interact to see
Advertisement

ACRS vs ANIK

Header iconACRS vs ANIK Comparison
Open Charts ACRS vs ANIKBanner chart's image
Aclaris Therapeutics
Price$1.56
Change-$0.07 (-4.29%)
Volume$994.06K
Capitalization168.92M
Anika Therapeutics
Price$10.84
Change-$0.39 (-3.47%)
Volume$783
Capitalization381.94M
ACRS vs ANIK Comparison Chart in %
Loading...
ACRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ANIK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACRS vs. ANIK commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACRS is a Buy and ANIK is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (ACRS: $1.56)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACRS’s FA Score shows that 1 FA rating(s) are green while.

  • ACRS’s FA Score: 1 green, 4 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACRS’s TA Score shows that 5 TA indicator(s) are bullish while ANIK’s TA Score has 4 bullish TA indicator(s).

  • ACRS’s TA Score: 5 bullish, 5 bearish.
  • ANIK’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, ANIK is a better buy in the short-term than ACRS.

Price Growth

ACRS (@Biotechnology) experienced а +9.86% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.59%. For the same industry, the average monthly price growth was +34.25%, and the average quarterly price growth was +14.95%.

Reported Earning Dates

ACRS is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+3.59% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ANIK($382M) has a higher market cap than ACRS($169M). ANIK YTD gains are higher at: -34.204 vs. ACRS (-37.097). ANIK has higher annual earnings (EBITDA): -11.23M vs. ACRS (-53.49M). ACRS has more cash in the bank: 105M vs. ANIK (72.9M). ANIK has higher revenues than ACRS: ANIK (167M) vs ACRS (17.8M).
ACRSANIKACRS / ANIK
Capitalization169M382M44%
EBITDA-53.49M-11.23M476%
Gain YTD-37.097-34.204108%
P/E RatioN/A72.99-
Revenue17.8M167M11%
Total Cash105M72.9M144%
Total DebtN/A29M-
FUNDAMENTALS RATINGS
ACRS vs ANIK: Fundamental Ratings
ACRS
ANIK
OUTLOOK RATING
1..100
778
VALUATION
overvalued / fair valued / undervalued
1..100
22
Undervalued
89
Overvalued
PROFIT vs RISK RATING
1..100
98100
SMR RATING
1..100
9896
PRICE GROWTH RATING
1..100
4687
P/E GROWTH RATING
1..100
10072
SEASONALITY SCORE
1..100
1045

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACRS's Valuation (22) in the Pharmaceuticals Other industry is significantly better than the same rating for ANIK (89). This means that ACRS’s stock grew significantly faster than ANIK’s over the last 12 months.

ACRS's Profit vs Risk Rating (98) in the Pharmaceuticals Other industry is in the same range as ANIK (100). This means that ACRS’s stock grew similarly to ANIK’s over the last 12 months.

ANIK's SMR Rating (96) in the Pharmaceuticals Other industry is in the same range as ACRS (98). This means that ANIK’s stock grew similarly to ACRS’s over the last 12 months.

ACRS's Price Growth Rating (46) in the Pharmaceuticals Other industry is somewhat better than the same rating for ANIK (87). This means that ACRS’s stock grew somewhat faster than ANIK’s over the last 12 months.

ANIK's P/E Growth Rating (72) in the Pharmaceuticals Other industry is in the same range as ACRS (100). This means that ANIK’s stock grew similarly to ACRS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACRSANIK
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 2 days ago
68%
Momentum
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 2 days ago
73%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 2 days ago
70%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 2 days ago
71%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 17 days ago
66%
Declines
ODDS (%)
Bearish Trend 10 days ago
85%
Bearish Trend 14 days ago
70%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 2 days ago
62%
Aroon
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 2 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
ACRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ANIK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SKSIX27.86N/A
N/A
AMG GW&K Small Cap Value I
AILIX11.94N/A
N/A
Cavanal Hill Hedged Equity Income Instl
FICVX35.58N/A
N/A
Fidelity Advisor Convertible Secs I
FEMMX41.90N/A
N/A
Fidelity Advisor Emerging Markets C
TASMX27.62N/A
N/A
Transamerica Small/Mid Cap Value R6

ANIK and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANIK has been loosely correlated with RVTY. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ANIK jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANIK
1D Price
Change %
ANIK100%
-3.56%
RVTY - ANIK
39%
Loosely correlated
+1.12%
AVNS - ANIK
35%
Loosely correlated
-0.81%
ACRS - ANIK
34%
Loosely correlated
-4.29%
FLGT - ANIK
32%
Poorly correlated
+0.15%
INFU - ANIK
32%
Poorly correlated
+0.94%
More